Lehman Financial Resources’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-2,047
Closed -$168K – 247
2015
Q3
$168K Buy
2,047
+38
+2% +$3.38K 0.09% 61
2015
Q2
$177K Hold
2,009
– – 0.09% 60
2015
Q1
$177K Buy
2,009
+335
+20% +$29.7K 0.08% 67
2014
Q4
$139K Sell
1,674
-335
-17% -$27.8K 0.07% 78
2014
Q3
$169K Buy
2,009
+1,116
+125% +$90.3K 0.09% 64
2014
Q2
$72K Hold
893
– – 0.03% 114
2014
Q1
$68K Hold
893
– – 0.04% 108
2013
Q4
$64K Hold
893
– – 0.04% 103
2013
Q3
$61K Buy
+893
New +$59.1K 0.04% 98

Other funds holding NVS

Lehman Financial Resources's NVS Position: Q4 2015 in Review

Lehman Financial Resources sold out of Novartis (NVS) in Q4 2015, closing a stake of 2,047 shares — an estimated $168K sold.

Lehman Financial Resources first reported a position in NVS in Q3 2013 and held it in 9 quarters. The position peaked at $177K in Q2 2015. 927 funds tracked by Wall St. Rank hold NVS as of Q4 2015.

  • Lehman Financial Resources reported no remaining Novartis position as of Q4 2015 after selling out during the quarter.
  • Lehman Financial Resources sold 2,047 Novartis shares in Q4 2015, an estimated $168K.
  • Lehman Financial Resources first reported a position in Novartis in Q3 2013 and held it in 9 quarters.
  • Lehman Financial Resources's Novartis position peaked at $177K in Q2 2015.
  • 927 funds tracked by Wall St. Rank held Novartis as of Q4 2015.

Based on Lehman Financial Resources's 13F filing for Q4 2015, filed 17 Feb 2016.